CARNA BIOSCIENCES
LIVE

Serial Number

79008908

Owner

CARNA BIOSCIENCES, INC.

Attorney

Michael S. Hargis

Filing Date

Jan 4, 2005

Add to watchlist:

No watchlists yet
View on USPTO

CARNA BIOSCIENCES Trademark

Serial Number: 79008908 • Registration: 3071237

CARNA BIOSCIENCES is a trademark filed by CARNA BIOSCIENCES, INC. on January 4, 2005. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CARNA BIOSCIENCES, INC. (2 trademarks)

5-5-2-511 Minatojima-Minamimachi Chuo-ku
Kobe-shi, Hyogo 650-0047 , JP

Entity Type: 03

Trademark Details

Filing Date

January 4, 2005

Registration Date

March 21, 2006

Published for Opposition

December 27, 2005

Goods & Services

[ Bacteriological research; ] biological research; [ chemical analysis; chemical research; chemistry services; cosmetic research; mechanical research; calibration measuring; and ] biological or chemical research consultancy

Peptide for in vitro research use and for scientific and medical research; polypeptide for in vitro research use and for scientific and medical research; protein for in vitro research use and for scientific and medical research; chemical reagents for non-medical purposes and non-veterinary purposes; and ferments for in vitro research use and for scientific and medical research

Chemical reagents for medical or veterinary purposes [; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; diagnostic preparations for medical purposes; drugs for medical purposes for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; medicines for human purposes for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; organotherapy preparations for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; pharmaceutical preparations for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; serotherapeutic medicines for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; pharmaceutical preparations for skin care; biological preparations for medical purposes; and ferments for medical or veterinary use ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 10, 2026 NA71
REGISTERED-SEC.71 ACCEPTED
Mar 10, 2026 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 9, 2026 APRE
TEAS SECTION 71 RECEIVED
Nov 10, 2025 ES71
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 27, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 27, 2025 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Oct 27, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 27, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 27, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 27, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 27, 2025 COAR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 21, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
Oct 10, 2024 RNWL
USPTO CORRECTION PROCESSED BY IB
Jan 17, 2019 RINX
GENERIC MADRID TRANSACTION SENT TO IB
Sep 13, 2017 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 13, 2017 XXCR
PARTIAL INVALIDATION PROCESSED BY THE IB
May 5, 2017 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Jan 18, 2017 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 18, 2017 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 4, 2016 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 4, 2016 NA71
REGISTERED-SEC.71 ACCEPTED
Apr 4, 2016 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 1, 2016 APRE
TEAS SECTION 71 RECEIVED
Jan 13, 2016 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 21, 2015 REM4
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 19, 2015 ADCH
INTERNATIONAL REGISTRATION RENEWED
Mar 12, 2015 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Mar 28, 2014 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 13, 2014 INPS
NEW REPRESENTATIVE AT IB RECEIVED
Nov 16, 2013 NREP
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 12, 2013 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 12, 2012 NA71
REGISTERED-SEC.71 ACCEPTED
Jun 12, 2012 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 12, 2012 APRE
TEAS SECTION 71 RECEIVED
Mar 16, 2012 ES71
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 2, 2007 FINO
LIMITATION OF GOODS RECEIVED FROM IB
Dec 14, 2006 LIMG
FINAL DISPOSITION NOTICE SENT TO IB
Oct 24, 2006 FICS
FINAL DISPOSITION PROCESSED
Oct 24, 2006 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 19, 2006 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 21, 2006 R.PR
PUBLISHED FOR OPPOSITION
Dec 27, 2005 PUBO
NOTICE OF PUBLICATION
Dec 7, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 8, 2005 PREV
ASSIGNED TO LIE
Nov 4, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2005 CNSA
AMENDMENT FROM APPLICANT ENTERED
Oct 19, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2005 CRFA
PAPER RECEIVED
Oct 5, 2005 MAIL
REFUSAL PROCESSED BY IB
Aug 25, 2005 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 9, 2005 RFCS
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 9, 2005 RFCR
NON-FINAL ACTION WRITTEN
Aug 8, 2005 CNRT
ASSIGNED TO EXAMINER
Aug 4, 2005 DOCK
NEW APPLICATION ENTERED
Mar 25, 2005 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 24, 2005 REPR